Member Info for RiskIsReward

Or sell whole COVID product to BC or someone and throw special dividend investors?

other than covid kit, they have - MT-RNR1, HCV and US DOD pathogen detection kits. TB kit in developement (would be take couple of years for this to be ready).
what is the fair value of GDR without covid kit?

I do agree with you that GDR provides simpler processes and even more throughput but you have to weigh that against the cost incurred to replace machines and time to train staff?
I’m sure all the sales leads would have gone some where else by now. Time is money in business world, no one has time to wait long.
GDR has best test new labs can show interest once approvals lands.

To give you an example of their sales strategy and timelines:
Received CE marking in May but EU distribution was setup in November.
SA Approvals recived in September, no sales till date.
EU deal supposed to be confirmed by now, but still no news
So dont pin too many hopes

I think we won't gain much traction in the current, Everybody has pcr machines to suitable to work with existing machine and Staff trained to work with reagents. Since ours is a different test it would be hard for existing labs to make changes.
We only have chance with new labs, they would only consider when we have approvals.

I dont think so, there are lot of PI's who average down are waiting too sell when EU sales RNS comes out. that i why BGF is keeping the price at this level.

But i doubt whether EU deal is still on.. anyways we would find out soon.. hold tight

On 22nd May RNS genedrive stated that Cytiva has capacity to prodcue 10,000 beads per hour.
My question to the company (not DB) how much capacity did you consume?

IMHO - Talk big in RNS and investor presentations quoting big numbers to fool PI's. This is just to convert loan notes or raise more funds. Last RNS of selling in America was aimed to bail out BGF out but unfortunately it did not work as expected. if you check carefully that RNS is states "validation of this test has not been reviewed by FDA. Review under the EUA program is pending" and for specimen testing only. In America it is all insurance based, no insurance company would allow pay out for such tests and no govt buys them with caveats unless it is UK (pun intended).

The only chance we have is get FDA/WHO untill then we stand no chance, I'm not expecting this any sooner as they are currently looking to authorise Antigen tests although they are not the best. Simple reason why BC put their Antigen test forward than our automated 1 step PCR and market also gave it a huge coverage. Some rampers tried to atrribute that to GDR but i think PI's were smart this time although it is little late for some.

can't beleive sold zero and buy 41 trades worth 65K, is this really true?

I own shares it means i can vote? if so could someone post the details of registering and voting here
Thanks in Advance

Merry Christmas guys!!

Lol
Last thing I wanted to hear before Xmas

And mega mega sell for BGF??

If the same news was released 2 months ago, we would be higher than £2.
At this point of time Investors are expecting confirmed sales and revenue. So the reaction..

BGF would offload 6.7m shares at some point before or after news... Which would give good entry point to some lucky ones ...

I feel i think the £2 days are gone.
but I still believe it recover close to £1 only provided if substantial sale lands in.
With current PI sentiment the approvals wont do much.

It was in same status in last week update, unless can someone tell what was changed?
https://extranet.who.int/pqweb/sites/default/files/documents/201208_EUL_SARS-CoV-2_product_list.pdf
IMHO - in the end we would get WHO approval, but by looking the speed of their approvals . They only approve a couple in a month and ours would be January u guess.

WHO Approved only 3 PCR tests in last 3 months time, looks they are not in a rush.

I was in same situation last week and sold out with a 30% loss.
bought back this morning at 51 and 52 bcos i still believe in this.

I think price provides perfect opportunity to buy.. Just bought back at 51 and 52..

I think RNS is good and current SP is a perfect buy opportunity IMHO. I’m going buy back today for mid/long term.
sold on pfizer news last week

Pipeline includes an advanced opportunity for supply to a Ministry of Health of a European country, which if converted to a sale, could be for low double digit millions of pounds and delivered in the first quarter of 2021

11 or 12 million deal?